SPERA PHARMA
Spera Pharma is the provider of chemistry research and analytical development in the pharmaceutical sector.
SPERA PHARMA
Social Links:
Industry:
Chemical Information Technology Pharmaceutical
Founded:
2017-07-01
Status:
Active
Technology used in webpage:
Euro Japanese Server Location
Similar Organizations
Aliophtha
Aliophtha is work on Research and development in the field of pharmaceutical products.
Doris Pharmaceuticals
Doris Pharmaceuticals is focused on business, regulatory, and clinical development information and consultation.
Jiangsu Jibeier Pharmaceuticals
Jiangsu Jibeier Pharmaceuticals is involved in the research and development of pharmaceuticals, and chinese patent medicine.
SS Bioanalytics
SS Bioanalytics offers services in bioanalytical method development, validation, sample analysis, and pharmacokinetic analysis.
Vitas-M Laboratory
Vitas-M Laboratory supplies chemical compounds for research and development in the pharmaceutical and agrochemical industries.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-07-30 | J-Pharma | Spera Pharma investment in Series D - J-Pharma | 1.75 M JPY |
More informations about "Spera Pharma"
SPERA PHARMA,Inc. President
SPERA PHARMA,Inc. President Chemical R&D Division Pharmaceutical Technology R&D Division Analytical R&D Division Investigational Medicinal Products Quality Assurance …See details»
Spera Pharma - Crunchbase Investor Profile & Investments
Legal Name Spera Pharma, Inc. Lists Featuring This Company. Edit Lists Featuring This Company Section. Investors Active in Japan . 4,411 Number of Organizations • $297.4B Total …See details»
SPERA PHARMA,Inc. President
SPERA PHARMA,Inc. President Office Chemical R&D Division Pharmaceutical Technology R&D Division Analytical R&D Division Investigational Medicinal Products Quality Assurance …See details»
Spera Pharma, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Spera Pharma, Inc. with its drug pipeline, therapeutic area, technology platform, 7 clinical trials, and 7 literature, Disease Domain:Nervous System Diseases ...See details»
Interprotein and SPERA PHARMA enter into an agreement for …
Feb 16, 2022 About SPERA PHARMA SPERA PHARMA is a CDMO (Contract Development & Manufacturing Organization) capable of undertaking a wide range of CMC (Chemistry, …See details»
SPERA PHARMA - Overview, News & Similar companies - ZoomInfo
SPERA PHARMA contact info: Phone number: +81 676536818 Website: www.spera-pharma.co.jp What does SPERA PHARMA do? SPERA PHARMA (SPERA) was spun out …See details»
SPERA PHARMA, Inc. | LinkedIn
SPERA PHARMA is exhibiting at the 21st Technical Symposium ! Dates: July 30th to –31st, 2024 Day 1: July 30th (Tue) 【Conference】9:20-17:20 (Registration begins at 8:30)【Welcome drink ...See details»
Takeda Announces Further Details of Transformational …
Osaka, Japan, May 15, 2017 ―Takeda Pharmaceutical Company Limited (“Takeda”) today announced that it has entered into an agreement for an absorption-type company split with its …See details»
SPERA PHARMA,Inc. President
SPERA PHARMA,Inc. President Office Chemical R&D Division Pharmaceutical Technology R&D Division Analytical R&D Division Investigational Medicinal Products Quality Assurance …See details»
Spera Pharma - PitchBook
Spera Pharma General Information Description. Provider of chemistry research and analytical development catering to the pharmaceutical sector. The company specializes in CMC …See details»
SPERA PHARMA, INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for SPERA PHARMA, INC. of OSAKA, OSAKA. Get the latest business insights from Dun & Bradstreet.See details»
Building The Foundation of Japan’s Premier CDMO
Sep 22, 2017 SPERA PHARMA, INC. In July 2017, the company’s CMC capabilities were extended further when Takeda spun-out part of its pharmaceutical sciences/CMC business — …See details»
The Remarkable Rise Of Japan's CDMOs - Outsourced Pharma
May 2, 2019 In 2017, Bushu Pharmaceuticals Ltd., one of the original Japanese contract organizations, and who lists “affiliations” with companies like Sandoz, Novartis, and Japan’s …See details»
News | SPERA PHARMA, Inc.
Sep 20, 2022 SPERA PHARMA made a debut exhibit at CPhI worldwide 2017, which was held for three days from October 24, 2017 in Frankfurt, Germany. Details of the SPERA PHARMA …See details»
Spera Pharma Begins Business Capitalizing on “Takeda’s” Track …
Spera Pharma, which took over part of Takeda Pharmaceutical’s Pharmaceutical Sciences (chemistry, manufacturing, and control) business amid the drug giant's R&D revamp, started …See details»
SPP-635 - Drug Targets, Indications, Patents - Synapse - Patsnap
Speedel Pharma AG Spera Pharma, Inc. Startup The Speedel Group + [1] Drug Highest Phase Discontinued Phase 2. First Approval Date-Regulation-Related. 3. Clinical Trials associated …See details»
SPERA PHARMA,Inc. President
SPERA PHARMA,Inc. President Office Chemical R&D Division Pharmaceutical Technology R&D Division Analytical R&D Division Investigational Medicinal Products Quality Assurance …See details»
Building the Foundation of Japan’s Premier CDMO - Pharma's …
The globalization of healthcare and the demand for drugs worldwide are continuously rising. Currently, the global pharmaceutical market is expanding at a robust compound annual growth …See details»
News | SPERA PHARMA, Inc.
A paper by Masatoshi Yamada and others of the Pharmaceutical Research Division has been published in the academic journal "Organic Process Research & Development" of the …See details»